Law360, New York (April 27, 2012, 8:38 PM ET) -- A British court handed a win Friday to Merck Sharp & Dohme Ltd. in its patent infringement suit against Sigma Pharmaceuticals PLC over the asthma medication Singulair, ruling Sigma violated European patent laws by importing the drug from Poland and selling it in the U.K.
The England and Wales Patents County Court held that Sigma was not protected by a section of the 2003 Act of Accession of Poland into the European Union that holds, in part, that anyone from Poland intending to import or market...
Merck Wins Patent Rights Suit Over Singulair Imports
To view the full article, take a free trial now.
